Best Percutaneous Coronary Intervention Podcasts (2024)

1
Revascularization: techniques,hardwares &procedures in PCI. 2021ACC/AHA/SCAI guidelines 17:23

2y ago17:23

17:23

Procedures & Techniques of PCI. 2021 ACC/AHA/SCAI guidelines.A discussion on Vascular access, stent types, Thrombectomy, CTO PCI, ISR, SVG - PCI, Hemodynamic Support for #PCI and many such topics. We have been discussing the 2021 #coronary revascularization guidelines given by #ACC. This is the 6th and the last video in this series. in this video w…

1
Revascularization in special situations.2021 ACC/AHA/SCAI GUIDELINES on Myocardial Revascularization 15:56

2+ y ago15:56

15:56

Revascularization in special situations - #pregnancy, old age, chronic kidney disease, cardiac allograft; revascularization to prevent ventricular tachycardia. Here is a discussion from 2021 ACC/AHA/SCAI GUIDELINES on Myocardial Revascularization. What to do in case of pregnancy? What to do in patients with #CKD? What to do in patients with old age…

1
ANTIPLATELET THERAPY AFTER PCI. 2021 ACC/AHA/SCAI GUIDELINES 27:39

2+ y ago27:39

27:39

ANTIPLATELET THERAPY BEFORE / DURING & AFTER PCI and CABG - 2021 ACC/AHA/SCAI GUIDELINES.A lot has changed in the field of Antiplatelet and antithrombotic therapy in patients undergoing #PCI or CABG. New evidence from trials like TWILIGHT trial, STOPDAPT trial, GLASSY & GLOBAL LEADER trial has made us reconsider what is optimal Antiplatelet Therapy…

1
TOMAHAWK trial. Angiography after Cardiac Arrest without ST elevation. NEJM 2021. ESC 2021 9:45

2+ y ago9:45

9:45

TOMAHAWK trial or Angiography after Out-of-Hospital Cardiac Arrest without ST-Segment Elevation trial was recently published in #NEJM New England journal of Medicine and presented at the European Society of Cardiology Virtual Congress in 2021. It tested the strategy of immediate coronary angiography vs delayed or selective coronary angiography in p…

1
PARADISE MI Trial. ARNI in Acute Myocardial Infarction. NEJM 2021/ ACC 2021 5:30

2+ y ago5:30

5:30

PARADISE MI Trial. ARNI in Acute Myocardial Infarction. NEJM 2021/ ACC 2021

1
Revascularization - stable CAD. ACC/AHA/SCAI guidelines 2021 23:14

2+ y ago23:14

23:14

Revascularization in stable CAD. ACC/AHA/SCAI guidelines 2021. Revascularization in stable CAD (coronary artery disease) had been a matter of debate in the field of Interventional Cardiology and cardiac surgery. What to do in patients with single vessel disease? What to do in patients with triple vessel disease?What to do in patients with Diabetes?…

1
Revascularization in NSTE-ACS. 2021 ACC/ AHA/ SCAI Guidelines myocardial revascularization 5:56

2+ y ago5:56

5:56

Revascularization in NSTE- ACS (Non ST segment elevation acute coronary syndrome). 2021 ACC/AHA/STS/SCAI guidelines for myocardial revascularization -2. A discussion on every old and new concept in 2021 guidelines for myocardial revascularization. This was a huge 100+ page document, so breaking it down for easier discussion into multiple parts. Thi…

1
Revascularization in STEMI. 2021 ACC/ AHA/ SCAI Guidelines 16:41

2+ y ago16:41

16:41

Revascularization in STEMI. 2021 ACC/AHA/STS/SCAI guidelines for myocardial revascularization -I. A discussion on every old and new concept in 2021 guidelines for myocardial revascularization. This was a huge 100+ page document, so breaking it down for easier discussion into multiple parts. This is first of many videos about to come on this documen…

1
EMPULSE Trial. EMPAGLIFLOZIN in Acute Heart Failure. 6:57

2+ y ago6:57

6:57

EMPULSE Trial. EMPAGLIFLOZIN in Acute Heart Failure.EMPULSE TRIAL. EMPAGLIFLOZIN in patients with acute decompensated heart failure. #heart #cad #heartfailure #aha#cardioed #cardio #cardiologist #cardiologia #cardiologie #cardiovascular

1
FFR. FRACTIONAL FLOW RESERVE. EVIDENCE & APPLICATIONS 33:24

2+ y ago33:24

33:24

Fractional Flow Reserve or FFR. #FFR. Fractional Flow Reserve is useful for assessment and management of intermediate coronary lesions, left main interventions, multivessel disease and stable CAD. #FractionalFlowReserve. Here is a discussion on applications of Fractional Flow Reserve OR FFR in Interventional Cardiology and the various trials suppor…

1
CHIEF HF Trial. CANAGLIFLOZIN in HEART FAILURE. AHA 2021 4:14

2+ y ago4:14

4:14

CHIEF HF Trial was recently presented at the AHA 2021 meeting. It tested an #SGLT2Inhibitor #CANAGLIFLOZIN in #HEARTFAILURE. CHIEF HF Trial or CANAGLIFLOZIN in HEART FAILURE which was recently presented at AHA 2021 is yet to be published. If you were searching about CHIEF HF Trial or role of CANAGLIFLOZIN in HEART FAILURE you can find it in this vi…

1
RAPID CABG Trial. AHA 2021. EARLY CABG AFTER TICAGRELOR.. 7:04

2+ y ago7:04

7:04

RAPID CABG Trial was recently presented at the AHA 2021. It tested the strategy of EARLY CABG AFTER TICAGRELOR vs delayed CABG after Ticagrelor administration.

1
CTCR - MVS Trial. Tricuspid valve repair in patients undergoing Mitral Valve surgery. AHA 2021. 8:48

2+ y ago8:48

8:48

CTCR - MVS Trial. Tricuspid valve repair in patients undergoing Mitral Valve surgery. AHA 2021. NEJM 2021.

1
REVERSE- IT Trial. Bentracimab for ticagrelor reversal. AHA 2021 6:10

2+ y ago6:10

6:10

REVERSE- IT Trial. Bentracimab for ticagrelor reversal. AHA 2021

1
AVATAR Trial. Aortic valve replacement in Asymptomatic Severe Aortic Stenosis. AHA 2021 11:19

2+ y ago11:19

11:19

AVATAR Trial. Aortic valve replacement in Asymptomatic Severe Aortic Stenosis. AHA 2021.

1
Revascularization in stable CAD -1. 19:00

2+ y ago19:00

19:00

How to manage patients with stable coronary artery disease. First part of the discussion - a look at all the contemporary data we have.

1
Best Antithrombotic Regimen after Watchman device? - JACC Interventions 10:20

2+ y ago10:20

10:20

Best Antithrombotic Regimen after Watchman device? - JACC Interventions

1
PCI in U.S. for stable CAD vs ISCHEMIA trial population - How different? (JACC Interventions) 5:45

2+ y ago5:45

5:45

In the latest edition of #JACC Interventions, this recently published study titled "Comparison of Patients Undergoing Percutaneous Coronary Intervention in Contemporary U.S. Practice With ISCHEMIA Trial Population" compared the patients in United States undergoing PCI for stable #coronary artery disease (#CAD) with recently published #ISCHEMIA stud…

1
ACTIVATION trial. PCI before TAVR - Should we do it? 8:13

2+ y ago8:13

8:13

The percutaneous coronary intervention prior to transcatheter aortic valve implantation (ACTIVATION) trial (#ACTIVATIONtrial) tested the strategy the #PCI before #TAVR Vs #TAVR without #PCI in patients with significant #CAD without significant #angina. Unfortunately the trial was terminated because of slow enrollment. Yet, it shed light on importan…

1
EMPEROR PRESERVED trial. Empagliflozin in HFpEF patients - Finally something works in HFpEF. 6:29

2+ y ago6:29

6:29

#EMPEROR PRESERVED trial was recently published in #NEJM in 2021. It was also presented at #ESC2021. Heart Failure with Preserved Ejection Fraction (#HFpEF) is responsible of more than half of the cases of heart failure. It is a difficult to diagnose and difficult to treat condition. #Emplagliflozin and #dapagloflozin are 2 #SGLT2inhibitors have be…

1
FAME - 3 trial. FFR guided PCI vs CABG in triple vessel disease 8:02

2+ y ago8:02

8:02

#FAME3 trial was recently published in #NEJM. Patients with three-vessel coronary artery disease have been found to have better outcomes with coronary-artery bypass grafting (#CABG) than with percutaneous coronary intervention (#PCI), but studies in which PCI is guided by measurement of fractional flow reserve (#FFR) have been lacking. The current …

1
The Wonder of Vivien Thomas - Bonus Episode 10:25

2+ y ago10:25

10:25

Thanks for listening to the 1st season of "The Wonder of", an original podcast series from Wondr Medical. To mark the end of Black History Month, we wanted to talk about one of the unsung heroes of modern medicine... An African-American laboratory technician and instructor of surgery at Johns Hopkins University, Baltimore, who was instrumental in t…

1
The Wonder of the Stent - Ulrich Sigwart and the Stent 7:40

2+ y ago7:40

7:40

Thanks for listening to "The Wonder of the Stent", an original podcast series from Wondr Medical. In the final episode of this season, we'll be hearing how a children’s toy called the 'Chinese Finger Trap' inspired cardiologist Ulrich Sigwart to alter the design of the Stent. And now, thirty-five years after the first experimental implantation, the…

1
The Wonder of the Stent - Andreas Grüntzig and coronary angioplasty 7:31

2+ y ago7:31

7:31

Welcome back to "The Wonder of the Stent", an original podcast series from Wondr Medical. In the 2nd episode of this season, we're continuing on the journey that Charles Dotters had set us on. At the time, a young physician called Andreas Grüntzig would attend a talk about "Dottering" at a clinical conference in Frankfurt. What he heard would blow …

1
The Wonder of the Stent - Charles Dotter and transluminal angioplasty 7:20

2+ y ago7:20

7:20

Would you like to know how to treat a blocked coronary artery using a guitar string, a rubber glove, a children’s toy and a set of dentures? Introducing "The Wonder of the Stent", an original podcast series from Wondr Medical. In the first episode of this mini-series, we'll be taking a look at the mind behind one of the most effective and frequentl…

1
Device related thrombosis after LA appendage occlusion. 8:18

3y ago8:18

8:18

#DeviceRelatedThrombosis after #LeftAtrialAppendageOcclusion is a problem which negates the very advantages of left atrial appendage occlusion. It increases the ischemic risk. The #LAAODRTregistry was a case control study of device related thrombosis in patients who received any of the left atrial appendage occlusion device like Watchman or ACP/Amu…

1
The Wonder of the Stent - Coming Soon 1:15

3y ago1:15

1:15

Welcome to the 'The Wonder of the Stent'. A new podcast series from the minds at Wondr Medical. Join our host, Dr Rohin Francis, aka 'Medlife Crisis', on a journey to uncover the development of one of the most effective and frequently performed procedures in modern medicine today: percutaneous coronary intervention, or Stenting. Subscribe for more …

1
Abelacimab for prevention of venous thromboembolism after knee replacement. NEJM 2021 5:57

3y ago5:57

5:57

#Abelacimab for #VenousThromboembolism prevention after #TotalKneeReplacement, published in July 2021 edition of #NEJM. #Abelacimab is #MonoclonalAntibody against #Factor XI, a key component of #intrinsicCoagulationPathway. It has been used in prevention of Venous Thromboembolism after Total Knee Replacement and compared to #Enoxaparin. In this stu…

1
ADAPTABLE TRIAL. aspirin doses for secondary prevention. NEJM 2021. 4:04

3y ago4:04

4:04

#ADAPTABLE trial was recently published in NEJM 2021 and it was also presented at ACC 2021 conference. It compared #HighDoseAspirin and #LowDoseAspirin in patients receiving it for secondary prevention. Follow Cardio-Ed for more such content. We discuss Recent advances, recent guidelines and recent articles in cardiology as well as core concepts in…

1
REHAB - HF trial & rehabilitation in older heart failure patients. 3:42

3y ago3:42

3:42

REHAB - HF trial was recently published in New England journal of medicine (NEJM) 2021 (July). It was also presented at the American College of Cardiology Virtual Annual Scientific Session (ACC 2021). The REHAB -HF trial tested the strategy of tailored rehabilitation program in older patients with acute heart failure. Acute heart failure in older p…

1
Omecamtiv mecarbil & GALACTIC-HF trial (NEJM 2021& JACC 2021) 8:11

3y ago8:11

8:11

Role of omecamtiv mecarbil in heart failure with reduced ejection fraction (HFrEF) was published in GALACTIC- HF trial (NEJM 2021). Recently, in JACC the effect of ejection fraction on response to Omecamtiv mecarbil in patients enrolled in GALACTIC-HF trial was published. In this presentation I have discussed both these studies together. Omecamtiv …

1
In stent restenosis - Risk factors, classification, restenosis, pathogenesis and management. 31:30

3y ago31:30

31:30

In stent restenosis is common after POBA. in the era of DES also, it is responsible for 10% of all PCI. In this podcast i have discussed about definition of ISR (in stent restenosis), classification of ISR (in stent restenosis), risk factors of ISR (in stent restenosis), investigations of ISR (in stent restenosis), management of ISR (in stent reste…

1
TTM-2 Trial. Therapeutic hypothermia after cardiac arrest. 12:57

3y ago12:57

12:57

Past, present and future of therapeutic hypothermia.Targeted temperature management (TTM) or Therapeutic hypothermia is recommended for patients after cardiac arrest, but the supporting evidence is of low certainty.TTM-2 trial was recently published in NEJM (June 2021).The TTM-2 trial tried to answer the question if Therapeutic hypothermia is any b…

1
Heart Failure with Preserved Ejection Fraction: What works and what doesn't in 2021. (HFpEF- Tt) 49:51

3y ago49:51

49:51

Heart Failure with Preserved Ejection Fraction (HFpEF) is responsible of more than half of the cases of heart failure. It is a difficult to diagnose and difficult to treat condition. In this lecture i have summarized the available and upcoming drugs and other treatment modalities and evidence supporting each decision we make in HFpEF management. Wh…

1
FLOWER - MI trial. FFR (vs CAG) in STEMI patients with multivessel disease 9:44

3y ago9:44

9:44

FLOWER- MI trial was published in NEJM May 2021.The trial tested the strategy of FFR guided complete revascularization in STEMI and compared it to the angiography guided complete revascularization. I have discussed the trial in the podcast.By Cardio-Ed

1
LAAOS-3 trial. 20:48

3y ago20:48

20:48

The LAAOS III was published in June 2021. The trial tested that if, on a background of anticoagulation, surgical left atrial appendage occlusion during cardiac surgery was beneficial or not. Do watch/ listen.By Cardio-Ed

1
Role of SGLT-2 inhibitors in Heart Failure with reduced ejection fraction 34:27

3y ago34:27

34:27

SGLT2 inhibitors are the new drugs which have been approved for heart failure with reduced ejection fraction (HFrEF). After the landmark EMPA-REG_OUTCOME, DECLARE TIMI 58, EMPEROR REDUCED and DAPA HF trials, empagliflozin and dapagliflozin have found a place in the management of HFrEF or heart failure. Lets discover what makes them special drugs in…

1
COVID-19 Vaccine-associated thrombosis 18:45

3y ago18:45

18:45

COVID-19 Vaccine Associated Thrombosis - What a medical practitioner should know? We have been listening about AstraZeneca vaccine associated thrombosis a lot. However, not much is known about this entity. I have tried to discuss Vaccine Associated Thrombosis in detail in this lecture. Do listen.By Cardio-Ed

1
Anticoagulation in COVID-19 patients 19:41

3y ago19:41

19:41

How to give anticoagulation in COVID-19 patients?How to choose the right patient, and right drug?How long to continue with anticoagulation in COVID19?I try to answer these questions. The presentation is not based on anecdotes/ experience. There arent any trials i am discussing here. Discussion strictly confined to International guidelines only.…

Podcasts Worth a Listen

Percutaneous Coronary Intervention Podcasts

Podcasts Worth a Listen

Quick Reference Guide